Transcription Factor Drug Development - Poster Submission 2021

Translating Transcription Factor-Druggable Approaches into Safe and Effective Therapeutics

Download the Agenda
6-9 July, 2020

“This conference will give us the unique and diverse perspectives to develop novel therapeutic modalities within the oncogenic transcription factor drug development field. ”

– Joey Azofeifa, CEO, Arpeggio Bio

“I am looking forward to sharing new data at this event and meeting with other pharma & biotech companies at this first TF-targeting conference.”

– Dr. Liandong Ma, President & VP of the Institute of R&D, Kintor Pharmaceuticals
Looking to showcase your recent work?

Our dedicated poster session is the perfect way to get your research noticed. In order to present a poster, you need to be registered as a delegate. The posters will be displayed online throughout the virtual event. 

Poster abstract submission deadline is on 25 June 2021

Posters should be a one page PDF in portrait orientation.

Abstracts received after this time may not be accepted so please submit your abstract as soon as possible!

If you have any questions please contact [email protected] 

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.